Why the study?
New evidence emerged since the 2016 MiECTiS position paper, prompting an updated expert consensus document on minimal invasive extracorporeal circulation.
Does minimal invasive extracorporeal circulation (MiECC) improve outcomes compared to conventional cardiopulmonary bypass in patients undergoing cardiac surgery?
Does minimal invasive extracorporeal circulation (MiECC) improve outcomes compared to conventional cardiopulmonary bypass in patients undergoing cardiac surgery?
This updated consensus document strongly advocates for the widespread adoption of MiECC in cardiac surgery to minimize physiologic derangements and improve clinical outcomes.
Answers are grounded in this paper and cite their sources.
Supports MiECC adoption in adult cardiac surgery protocols; extends guideline evidence for perfusion biocompatibility and safety.
The landmark 2016 Minimal Invasive Extracorporeal Technologies International Society (MiECTiS) position paper promoted the creation of a common language between cardiac surgeons, anesthesiologists and perfusionists which led to the development of a stable framework that paved the way for the advancement of minimal invasive perfusion and related technologies. The current expert consensus document offers an update in areas for which new evidence has emerged. In the light of published literature, modular minimal invasive extracorporeal circulation (MiECC) has been established as a safe and effective perfusion technique that increases biocompatibility and ultimately ensures perfusion safety in all adult cardiac surgical procedures, including re-operations, aortic arch and emergency surgery. Moreover, it was recognized that incorporation of MiECC strategies advances minimal invasive cardiac surgery (MICS) by combining reduced surgical trauma with minimal physiologic derangements. Minimal Invasive Extracorporeal Technologies International Society considers MiECC as a physiologically-based multidisciplinary strategy for performing cardiac surgery that is associated with significant evidence-based clinical benefit that has accrued over the years. Widespread adoption of this technology is thus strongly advocated to obtain additional healthcare benefit while advancing patient care.
No takes yet. Share an insight, caveat, or question.
Anastasiadis et al. (2022) conducted a review in Cardiac surgery. Minimal invasive extracorporeal circulation (MiECC) vs. Conventional cardiopulmonary bypass (cCPB) was evaluated. Modular minimal invasive extracorporeal circulation (MiECC) is established as a safe and effective perfusion technique that increases biocompatibility and ensures perfusion safety in adult cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: